Aurobindo Pharma receives NCLT approval for scheme of amalgamation

Aurobindo Pharma announced that it received the approval of the Hon'ble National Company Law Tribunal, Hyderabad bench vide order dated 30 March 2021 for the modified scheme of amalgamation of wholly owned subsidiaries of Aurobindo Pharma viz., APL Healthcare and APL Research Centre and Aurozymes and Curepro Parenterals and Hyacinths Pharma and Silicon Life Sciences with Aurobindo Pharma.

Powered by Capital Market - Live News